Skip to content

A prospective randomized controlled study of growth hormone improve embryo aneuploidy in preimplantation genetic test patiets

A prospective randomized controlled study of growth hormone improve embryo aneuploidy in preimplantation genetic test patiets

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052433
Enrollment
Unknown
Registered
2021-10-26
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Test group:Growth hormone pretreatment
control group:none

Sponsors

CITIC Xiangya Reproductive and Genetic Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged >= 35 years in our hospital with PGT-A assisted pregnancy; 2. Our hospital's PGT-A assisted pregnancy pointer (any of the following): (1) Repeated miscarriage, embryo stoppage, and biochemical pregnancy >= 2 times; (2) A history of chromosomal abnormalities in aborted embryos in the past; (3) Repeated implantation failure (transplantation >= 3 times without pregnancy; or transplantation of high-quality embryos or blastocysts without pregnancy for 2 times).

Exclusion criteria

Exclusion criteria: 1. Past tumor history or tumor risk factors; 2. Patients with severe acute and chronic liver and kidney diseases, such as liver cirrhosis, acute and chronic renal failure, active hepatitis B virus, etc.; patients with abnormal liver and kidney functions; 3. Uncontrolled endocrine and metabolic diseases and adrenal diseases; 4. Rheumatic immune diseases; or are using immunosuppressive agents; 5. Those who have been allergic to growth hormone products in the past; 6. Participating in other drug clinical investigators; 7. Others deemed unsuitable for inclusion by the investigator.

Design outcomes

Primary

MeasureTime frame
euploidy rate of blastocyst;

Countries

China

Contacts

Public ContactZhang Shunji

CITIC Xiangya Reproductive and Genetic Hospital

12214877@qq.com+86 18684741202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026